🥝GuideKiwi
Free Guide

Learn About Macular Degeneration Treatment Options and Eye Care

Understanding Macular Degeneration: Types and Causes Macular degeneration, also called age-related macular degeneration (AMD), is a condition that affects th...

GuideKiwi Editorial Team·

Understanding Macular Degeneration: Types and Causes

Macular degeneration, also called age-related macular degeneration (AMD), is a condition that affects the macula—the small area in the center of the retina responsible for sharp, detailed vision. The macula allows you to read, recognize faces, drive, and perform tasks that require clear central vision. When the macula deteriorates, central vision becomes blurry or distorted, though peripheral (side) vision usually remains intact.

There are two main types of macular degeneration: dry AMD and wet AMD. Dry AMD, also called atrophic AMD, accounts for about 80 to 90 percent of all cases. In dry AMD, yellow deposits called drusen build up under the retina. These deposits are made of lipids and proteins. Over time, the light-sensitive cells in the macula gradually break down, causing vision loss that develops slowly over months or years. The progression varies widely—some people experience minimal vision loss, while others develop more significant impairment.

Wet AMD, also called neovascular or exudative AMD, is less common but typically more serious. In wet AMD, abnormal blood vessels grow beneath the retina and macula. These fragile vessels leak fluid or blood, causing the macula to swell and become damaged. Vision loss in wet AMD can happen quickly, sometimes over weeks or days. Early detection and treatment are especially important for wet AMD because intervention can help slow vision loss.

Several factors increase the risk of developing macular degeneration. Age is the strongest risk factor—the condition is most common in people over 55 years old. According to the American Academy of Ophthalmology, about one in three people over age 75 have some signs of AMD. Family history matters too; if your parents or siblings had AMD, your risk is higher. Smoking is a major modifiable risk factor that roughly doubles the risk of developing AMD. Other contributing factors include high blood pressure, high cholesterol, obesity, and prolonged sun exposure without eye protection.

Practical Takeaway: Understanding whether you have dry or wet AMD shapes which treatment options may work for you. If you're over 55 or have family members with AMD, talking with an eye care professional about your personal risk can help you make informed decisions about monitoring and prevention.

Recognizing Early Signs and Symptoms

Early detection of macular degeneration can make a real difference in outcomes, particularly for wet AMD. Many people don't notice symptoms in the earliest stages, which is why regular eye examinations are valuable. Knowing what to watch for helps you catch changes and report them to your eye care provider promptly.

Common early symptoms of AMD include blurred or fuzzy central vision, difficulty recognizing faces even when people are close by, and trouble reading or doing detailed work without increasingly bright light. Some people notice that colors appear less vibrant or that there's a dark or empty area in the center of their vision. Straight lines may appear wavy or bent—a symptom called metamorphopsia that often signals wet AMD and warrants urgent evaluation by an eye care professional.

The Amsler grid is a simple tool that can help you monitor your vision at home. This grid looks like a small checkerboard with a dot in the center. You focus on the center dot while looking at the lines around it. If the lines appear wavy, broken, or if you notice dark spots or blank areas, these changes could indicate macular degeneration, especially wet AMD. Many eye care offices provide Amsler grids, and they're also available online. Using the grid once daily, preferably at the same time each day, helps you notice changes in vision that might otherwise go undetected.

Vision changes don't always mean you have AMD—other conditions like cataracts, diabetic retinopathy, or refractive errors can cause similar symptoms. That's why a comprehensive eye examination by an ophthalmologist or optometrist is essential for accurate diagnosis. During an eye exam, your provider will dilate your pupils to view the retina and macula closely, check your visual acuity, and may perform imaging tests like optical coherence tomography (OCT) or fluorescein angiography to get detailed pictures of your retina.

Practical Takeaway: Start using an Amsler grid today if you're at risk for AMD, and schedule an eye exam if you notice changes in your central vision. Regular monitoring between appointments helps catch changes early when treatment options tend to be most effective.

Treatment Options for Wet Age-Related Macular Degeneration

Several treatment approaches exist for wet AMD, and the right option depends on the specific characteristics of your condition, the stage of disease, and other health factors. Your ophthalmologist will recommend treatment based on the results of eye exams and imaging tests. Early treatment typically leads to better outcomes than waiting, since wet AMD can progress rapidly.

Anti-vascular endothelial growth factor (anti-VEGF) injections are currently the most common treatment for wet AMD. These medications work by blocking a protein called VEGF that signals the body to form new blood vessels. By reducing VEGF, these injections slow the growth of abnormal blood vessels and reduce leakage. Medications in this class include bevacizumab (Avastin), ranibizumab (Lucentis), aflibercept (Eylea), and brolucizumab (Beovu). These medications are injected directly into the eye during an office procedure. The eye is numbed with drops, and the injection takes only a few seconds. Most patients require injections every 4 to 12 weeks, depending on the medication and how their eye responds to treatment.

Photodynamic therapy (PDT) is another treatment option that may be used in certain cases. During PDT, a light-sensitive medication called verteporfin is injected into a vein in your arm. The medication travels through your bloodstream to the abnormal blood vessels in your eye. A special laser is then applied to activate the medication, which destroys the abnormal vessels while minimizing damage to surrounding tissue. PDT is less commonly used now than anti-VEGF therapy but may still be recommended in specific situations.

Laser photocoagulation uses a focused beam of light to destroy abnormal blood vessels. This treatment may be considered when abnormal vessels are located in certain positions relative to the fovea (the center of the macula). However, laser treatment can create a permanent blind spot, which is why it's typically reserved for specific cases where the benefits outweigh this risk.

Corticosteroid injections or implants may be used to reduce inflammation and swelling in the macula. These might be considered alongside or instead of anti-VEGF therapy depending on your situation. Some implants slowly release medication over several months, reducing the need for frequent injections.

Practical Takeaway: Anti-VEGF injections are the first-line treatment for most cases of wet AMD. If your eye care provider recommends injections, understanding the procedure and the expected treatment schedule helps you prepare and know what to expect during ongoing care.

Managing Dry Age-Related Macular Degeneration

Dry AMD progresses more slowly than wet AMD, and treatment focuses on slowing the disease progression and managing symptoms. Currently, no medication reverses dry AMD, but research-backed approaches can help reduce the rate of vision loss in some cases.

Nutritional supplementation has strong evidence supporting its role in slowing dry AMD progression. The Age-Related Eye Disease Study (AREDS), a major clinical trial funded by the National Eye Institute, found that high-dose vitamins and minerals reduced the risk of progression to advanced AMD by about 25 percent in people with intermediate AMD or advanced AMD in one eye. The AREDS formula contains vitamin C, vitamin E, beta-carotene, zinc, and copper. A follow-up study (AREDS2) tested a modified formula that substituted lutein and zeaxanthin for beta-carotene, since beta-carotene may increase lung cancer risk in smokers. The AREDS2 formula also added omega-3 fatty acids. Many eye care providers recommend AREDS or AREDS2 formulations for people with intermediate or advanced dry AMD.

Dietary choices support eye health and may slow AMD progression. Research suggests that diets rich in dark leafy greens (spinach, kale), colorful vegetables, and fatty fish (salmon, sardines, mackerel) rich in omega-3 fatty

🥝

More guides on the way

Browse our full collection of free guides on topics that matter.

Browse All Guides →